U.S. markets open in 5 hours 27 minutes

TransMedics Group, Inc. (TMDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.84+0.78 (+4.32%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Engulfing Line (Bearish)

Engulfing Line (Bearish)

Previous Close18.06
Open18.17
Bid14.38 x 800
Ask0.00 x 800
Day's Range17.93 - 19.04
52 Week Range10.10 - 25.47
Volume249,196
Avg. Volume192,814
Market Cap532.84M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.85
Earnings DateAug 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • TransMedics (TMDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
    Zacks

    TransMedics (TMDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

    TransMedics (TMDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    TransMedics to Present at the Canaccord 40th Annual Growth Conference

    ANDOVER, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today that members of management will be presenting at the virtual Canaccord 40th Annual Growth Conference. The presentation will take place on Thursday, August 13, 2020 at 10:00 a.m. EDT. Event: Canaccord 40th Annual Growth Conference Date: Thursday, August 13, 2020 Time: 10:00 a.m. EDTA live and archived webcast of the event will be available on the “Investors” section of the TransMedics website at www.transmedics.com. About TransMedics Group, Inc. TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.Investor Contact: Brian Johnston 631-807-1986 Investors@transmedics.com

  • Speculative TransMedics Group Looks Ready to Start an Upside Move
    TheStreet.com

    Speculative TransMedics Group Looks Ready to Start an Upside Move

    During the fast-paced "Lightning Round" segment of Mad Money Monday evening, one caller asked Jim Cramer about TransMedics Group : "That's a speculative situation but I bless it," said Cramer. Let's check out a couple of charts.